These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2506876)

  • 1. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
    Ferroni R; Milani L; Simoni D; Orlandini P; Guarneri M; Franzé D; Bardi A
    Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and platelet aggregation inhibitory effects of N-[(1H-pyrazol-1-yl)alkyl]benzoylamides.
    Ferroni R; Milani L; Simoni D; Orlandini P; Bottura M; Bardi A; Guarneri M
    Arzneimittelforschung; 1990 Jun; 40(6):705-9. PubMed ID: 2397007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,5-Diphenyl-1H-pyrazole derivatives. IX. 2-substituted 4-phenyl-5-(3,5-diphenyl-1H-pyrazol-1-yl) pyrimidines with platelet antiaggregating and other activities.
    Bondavalli F; Bruno O; Ranise A; Schenone P; D'Amico M; Parrillo C; Filippelli W; Rossi F
    Farmaco; 1992 Feb; 47(2):171-90. PubMed ID: 1510792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,5-Diphenyl-1H-pyrazole derivatives. VIII. N-substituted 3-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)-propanamides, -propanamines and 2-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)ethanamines with platelet antiaggregating, hypotensive, antiarrhythmic and other activities.
    Bruno O; Bondavalli F; Ranise A; Schenone P; Cenicola ML; Donnoli D; Filippelli W; Losasso C; Costantino M; Marmo E
    Farmaco; 1991 Mar; 46(3):477-99. PubMed ID: 1892504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5-Diphenyl-1H-pyrazole derivatives. VI--Esters and 2-dialkylaminoethyl ethers of 1(2-hydroxy-2-phenylethyl)-3,5-diphenyl-1H-pyrazole and N,N-disubstituted 1-(2-amino-2-phenylethyl)-3,5-diphenyl-1H-pyrazoles with depressant and platelet antiaggregating activities.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Losasso C; Stella L; de Paola C; Ioia N; Marmo E
    Farmaco; 1990 May; 45(5):511-26. PubMed ID: 2222723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Aryl-1H-pyrazole-5-acetic acids with antiinflammatory, analgesic and other activities.
    Menozzi G; Mosti L; Schenone P; D'Amico M; Falciani M; Filippelli W
    Farmaco; 1994 Feb; 49(2):115-9. PubMed ID: 8003179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,5-Diphenyl-1H-pyrazole derivatives. IV--N,N-disubstituted 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamides and 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamines with sedative, platelet antiaggregating and local anesthetic activities.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Losasso C; Donnoli D; Stella L; Marmo E
    Farmaco; 1990 Feb; 45(2):137-46. PubMed ID: 2133991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,5-Diphenyl-1H-pyrazole derivatives. VII--Esters, 2-dialkylaminoethyl ethers and N-substituted carbamates of 1-(2-hydroxy-3-phenoxypropyl)-3,5-diphenyl-1H-pyrazole with depressant and platelet antiaggregating activities.
    Bruno O; Bondavalli F; Ranise A; Schenone P; Losasso C; Cenicola ML; Stella L; Donnoli D; Marmo E
    Farmaco; 1990 May; 45(5):527-43. PubMed ID: 2222724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones.
    Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M
    Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amidinosemicarbazido derivatives of pyrazole: synthesis and inhibitory effect on blood coagulation and platelet aggregation.
    Ferroni R; Milani L; Simoni D; Orlandini P; Poli T; Guarneri M; Taddeo U
    Farmaco Sci; 1988 Nov; 43(11):891-9. PubMed ID: 3251783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-substituted 4-carboxy-1-phenyl-1H-pyrazole-5-propanamides with antiinflammatory, analgesic, antipyretic and platelet antiaggregating activities.
    Menozzi G; Mosti L; Schenone P; D'Amico M; Falzarano C; Rossi F
    Farmaco; 1993 Apr; 48(4):539-49. PubMed ID: 8357469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and platelet aggregation inhibitory activity of 10-oxa and 10-thia prostanoic acid derivatives.
    Das J; Vu T
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():788-93. PubMed ID: 2960192
    [No Abstract]   [Full Text] [Related]  

  • 15. New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological target.
    Biagi G; Giorgi I; Livi O; Scartoni V; Catalani R; Gervasi G
    Farmaco; 1996 Dec; 51(12):761-6. PubMed ID: 9050207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,5-Diphenyl-1H-pyrazole derivatives. XII. N-substituted 4-amino-1-(2-hydroxy- or 2-alkylaminoethyl)-3,5-diphenyl-1H-pyrazoles with local anesthetic, analgesic and platelet antiaggregating activities.
    Bruno O; Ranise A; Bondavalli F; Schenone S; D'Amico M; Falciani M; Vacca C; Filippelli A
    Farmaco; 1994 Sep; 49(9):533-40. PubMed ID: 7811347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-Diphenyl-1H-pyrazole derivatives. X. N-substituted 1-(2-aminopropyl)- and 1-(3-amino-2-hydroxypropyl)-3,5-diphenyl-1H-pyrazoles with antiinflammatory and other activities.
    Bruno O; Ranise A; Bondavalli F; Schenone P; D'Amico M; Lampa E; Falzarano C; Rossi F
    Farmaco; 1992 Oct; 47(10):1235-48. PubMed ID: 1482515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Farmaco Sci; 1986 Mar; 41(3):205-14. PubMed ID: 3086120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
    Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
    Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.